VoxNeuro began with a gap that any clinician assessing cognition will recognize. The standard tools, from pen-and-paper tests to questionnaires to clinical interviews, all depend on what a patient can report and what an examiner observes. They are subjective, they vary from one examiner to the next, and they say nothing about what is happening in the brain itself while a patient attends, remembers or decides.
For more than three decades, Dr. John F. Connolly’s lab at McMaster University worked on a harder version of that problem: how to measure cognitive function in people who could not take a test at all, including patients in a coma or with severe brain injury. The answer was in the brain’s electrical activity. When a person is given a cognitive task, the brain produces measurable and reliable electrical responses, known as event-related potentials, with a timing and peak that can be recorded by EEG. That science has been described in thousands of peer-reviewed papers, but it had remained in the research lab.
In 2017, John, James Connolly and Kimberly Elliott founded VoxNeuro to bring it into everyday clinical practice. The goal was not to replace the clinician’s judgment but to give it something it had been missing: an objective, examiner-independent measurement of brain activity during cognition, normalized against a reference population, that a qualified clinician can evaluate alongside everything else they know about a patient.
Why this approach
We chose EEG/ERP for three reasons. It is built on decades of established cognitive-neuroscience paradigms, so the measures mean something to clinicians and researchers alike. It captures brain responses at the millisecond scale, which is where cognition happens. And it fits in a clinic, a hospital or mobile setting: a 20–30 minute session, needs no scanner, and produces a cloud-based report that a clinician can act on instantaneously.
That work became the Cognitive Function Neuroimaging (cfNI) Software, FDA-cleared in 2026 for use by qualified healthcare professionals in adults 18 to 70. Today VoxNeuro supports neurologists, primary care physicians, nurse practitioners and medical practices across the United States, and we still measure ourselves by the same standard we started with: give clinicians objective data they can trust while giving everyone’s brain a voice.
cfNI provides objective EEG/ERP measures to support interpretation by a qualified healthcare professional. It does not provide a diagnosis or clinical interpretation. Prescription use only.
Read McMaster’s account of VoxNeuro’s origins ↗